Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 9, 1996, Pages 1001-1009

  Yuen, Violet G ^a   Pederson, Raymond A ^a   Dai, Soter ^a   Orvig, Chris ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

bis(maltolato)oxovanadium(IV); Hypertension; Insulin resistance; Zucker rat

Indexed keywords

INSULIN; VANADIUM DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS PERFUSION; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN; RATS; RATS, ZUCKER; VANADIUM;

EID: 0030471334     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-74-9-1001     Document Type: Article

References (57)

1. Bailey, C.J., and Flatt, P.R. 1993. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes. Diabetes Metab. Rev. 9: 43S-50S.
2. Battell, M.L., Yuen, V.G., and McNeill, J.H. 1992. Treatment of BB rats with vanadyl sulfate. Pharmacol. Commun. 1: 291-301.
3. Bhanot, S., and McNeill, J.H. 1994. Vanadyl sulfate lowers plasma insulin and blood pressure in spontaneously hypertensive rats. Hypertension (Dallas), 24: 625-632.
4. Bhanot, S., McNeill, J.H., and Bryer-Ash, M. 1994. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension (Dallas), 23: 308-312.
5. Boulange, A., Planche, E., and De Gasquet, P. 1981. Onset and development of hypertriglyceridemia in the Zucker rat (fa/fa). Metabolism, 30: 1045-1052.
6. Bray, G.A. 1977. The (fa/fa) Zucker-fatty rat: a review. Fed. Proc. 36: 148-153.
7. Brichard, S.M., Okitolanda, W., and Henquin, J.C. 1988. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology (Baltimore), 123: 2048-2053.
8. Brichard, S.M., Pottier, A.M., and Henquin, J.C. 1989. Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology (Baltimore), 125: 2510-2516.
9. Brichard, S.M., Bailey, C.J., and Henquin, J.C. 1990. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes, 39: 1326-1332.
10. Brichard, S.M., Ongemba, L.M., and Henquin, J.C. 1992. Oral vanadate decreases muscle insulin resistance in obese fa/fa rats. Diabetologia, 35: 522-527.
11. Chan, C.B., Pederson, R.A., Buchan, A.M.J., Tubesing, K.B., and Brown, J.C. 1984. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Diabetes, 33: 536-542.
12. Cohen, N., Halberstam, M., Shlimovich, P., Chang, C.J., Shamoon, H., and Rossetti, L. 1995. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 95: 2501-2509.
13. Curry, D.L., and Stern, J.S. 1985. Dynamics of insulin hypersecretion by obese Zucker rats. Metab. Clin. Exp. 34: 791-796.
14. Dai, S., and McNeill, J.H. 1992. Myocardial performance of STZ-diabetic DOCA-hypertensive rats. Am. J. Physiol. 263: H1798-H1805.
15. Dai, S., Fraser, H., and McNeill, J.H. 1992. Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats. Can. J. Physiol. Pharmacol. 70: 1468-1472.
16. Dai, S., Todd, M.E., Lee, S., and McNeill, J.H. 1994. Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats. Can. J. Physiol. Pharmacol. 72: 771-781.
17. DeFronzo, R.A., and Ferrannini, E. 1991. Insulin resistance - a multifaceted syndrome responsible for noninsulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care, 14: 173-194.
18. de Tata, V., Novelli, M., Cavallini, G., Masiello, P., Gori, Z., and Bergamini, E. 1993. Beneficial effects of the oral administration of vanadyl sulphate on glucose metabolism in senescent rats. J. Gerontol. 48: B191-B195.
19. Ferrari, P., and Weidmann, P. 1990. Insulin, insulin sensitivity and hypertension. J. Hypertens. 8: 491-500.
20. Furnsinn, C., Komjati, M., Madsen, O.D., Schneider, B., and Waldhausl, W. 1991. Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet. Endocrinology (Baltimore), 128: 1093-1099.
21. Goldfine, A.B., Simonson, D.C., Folli, F., Patti, M.E., and Kahn, C.R. 1995. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80: 3311-3320.
22. Herbert, V., Lau, K., Gottlieb, C.W., and Bleicher, S.J. 1965. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. 25: 1375-1384.
23. Heyliger, C.E., Tahiliani, A.C., and McNeill, J.H. 1985. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science (Washington, D.C.), 227: 1474-1477.
24. Ionescu, E., Sauter, J.F., and Jeanrenaud, B. 1985. Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am. J. Physiol. 248: E500-E506.
25. Kasiske, B.L., O'Donnell, M.P., and Keane, W.F. 1992. The Zucker rat model of obesity, insulin resistance, hyperlipidemia and renal injury. Hypertension (Dallas), 19: I110-I115.
26. Koh, G., Seino, Y., Usami, M., Matsuo, T., Ikeda, H., Yamamoto, T., Tsuda, K., Taminato, T., and Imura, H. 1990. Importance of impaired insulin-gene expression in occurrence of diabetes in obese rats. Diabetes, 39: 1050-1056.
27. Kurtz, T.W., Morris, R.C., and Pershadsingh, H.A. 1989. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension (Dallas), 13: 896-901.
28. Lucas, C.P., Estigarribia, J.A., Darga, L.L., and Reaven, G.M. 1985. Insulin and blood pressure. Hypertension (Dallas), 7: 702-706.
29. McCaleb, M., and Sredy, J. 1992. Metabolic abnormalities of the hyperglycemic obese Zucker rats. Metabolism, 41: 522-525.
30. McNeill, J.H., Yuen, V.G., Hoveyda, H.R., and Orvig, C. 1992. Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. J. Med. Chem. 35: 1489-1491.
31. Paulson, D.J., and Tahiliani, A.G. 1992. Minireview: cardiovascular abnormalities associated with human and rodent obesity. Life Sci. 51: 1557-1569.
32. Pawloski, C.M., Kanagy, N.L., Mortensen, L.H., and Fink, G.D. 1992. Obese Zucker rats are normotensive on normal and increased sodium intake. Hypertension (Dallas), 19: I90-I95.
33. Pederson, R.A., Buchan, M.A.J., Zahedi, A.S., Chan, C.B., and Brown, J.C. 1982. Effect of jejunoilial bypass on the enteroinsular axis. Regul. Pept. 5: 53-63.
34. Pederson, R.A., Ramanadham, S., Buchan, M.A.J., and McNeill, J.H. 1989. Long-term effects of vanadyl treatment of streptozocin-induced diabetes in rats. Diabetes, 38: 1390-1395.
35. Ramanadham, S., Mongold, J.J., Brownsey, R.W., Cros, G.H., and McNeill, J.H. 1989. Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am. J. Physiol. 257: H904-H911.
36. Ramanadham, S., Cros, G.H., Mongold, J.J., Serrano, J.J., and McNeill, J.H. 1990. Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin. Can. J. Physiol. Pharmacol. 68: 486-491.
37. Reaven, G.M., and Hoffman, B.B. 1987. A role for insulin in the aetiology and course of hypertension. Lancet, 2: 435-437.
38. Rodrigues, B., and McNeill, J.H. 1986. Cardiac function in spontaneously hypertensive diabetic rats. Am. J. Physiol. 251: H571-H580.
39. Rossetti, L., Giaccari, A., Klein-Robbenhaar, E., and Vogel, L.R. 1990. Insulinomimetic properties of trace elements and characterization of their in vivo mode of action. Diabetes, 39: 1243-1250.
40. Scheen, A.J., Paquot, N., Catillo, M.J., and Lefebvre, P.J. 1994. How to measure insulin action in vivo. Diabetes Metab. Rev. 10: 151-188.
41. Schenk, J., Hebden, A., and McNeill, J.H. 1992. Measurement of cardiac left ventricular pressure in conscious rats using a fluid-filled catheter. J. Pharmacol. Toxicol. Methods, 27: 171-175.
42. Schenk, J., Hebden, R.A., Dai, S., and McNeill, J.H. 1994. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats. Pharmacology, 48: 211-215.
43. Shafir, E. 1992. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 8: 179-208.
44. Shechter, Y. 1990. Perspectives in diabetes. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes, 39: 1-5.
45. Sherman, W.M., Katz, A.L., Cutler, C.L., Withers, R.T., and Ivy, J.L. 1988. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am. J. Physiol. 255: E374-E382.
46. Slieker, L.J., Roberts, E.F., Shaw, W.M., and Johnson, W.T. 1990. Effect of streptozotocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes, 39: 619-625.
47. Sodoyez, J.C., Sodoyez-Goffaux, F., Treves, S., Kahn, C.R., and van Frenckell, R. 1984. In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats. Diabetologia, 26: 229-233.
48. Sowers, J.R., Khoury, S., Standley, P., Zemel, P., and Zemel, M. 1991. Mechanisms of hypertension in diabetes. Am. J. Hypertens. 4: 177-182.
49. Standley, P.R., Zhang, F., Ram, J.L., Zemel, M.B., and Sowers, J.R. 1991. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J. Clin. Invest. 88: 1230-1236.
50. Standley, P.R., Ram, J.L., and Sowers, J.R. 1993. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats. Endocrinology (Baltimore), 133: 1693-1699.
51. Verma, S., Bhanot, S., and McNeill, J.H. 1994. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J. Pharmacol. Exp. Therap. 271: 1334-1337.
52. Yuen, V.G., Orvig, C., and McNeill, J.H. 1993a. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Can. J. Physiol. Pharmacol. 71: 263-269.
53. Yuen, V.G., Orvig, C., Thompson, K.H., and McNeill, J.H. 1993b. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). Can. J. Physiol. Pharmacol. 71: 270-276.
54. Yuen, V.G., Orvig, C., and McNeill, J.H. 1995. Comparison of the glucose lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can. J. Physiol. Pharmacol. 73: 55-78.
55. Zemel, M.B., Peuler, J.D., Sowers, J.R., and Simpson, L. 1992. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am. J. Physiol. 262: E368-E371.
56. Zucker, L.M. 1965. Hereditary obesity in the rat associated with hyperlipidemia. Ann. N.Y. Acad. Sci. 131: 447-458.
57. Zucker, L.M., and Zucker, T.F. 1961. Fatty Zucker, a new mutation in the rat. J. Hered. 52: 275-278.